The single site activating mutation Arg665Trp in PLCγ2 is known to occur in the context of ibrutinib resistance in chronic lymphocytic leukemia (4, 5, 15). This evidence concerns the gene PLCG2 and B-cell chronic lymphocytic leukemia.